跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“PRC2”
全部
72
临床试验
45
药物
11
机构
3
资讯
13
3个月前
FDA Safety Concerns Force Fulcrum Therapeutics to Halt Sickle Cell Drug Development
2年前
ORIC Pharmaceuticals Presents Promising Data on Cancer Drug Candidates at AACR Meeting
10个月前
ORIC Pharmaceuticals Completes Dose Exploration for ORIC-944 in Prostate Cancer, Shows Promising Efficacy Signals
2年前
Stifel Initiates Coverage on ORIC Pharmaceuticals with Buy Rating and $20 Target
去年
Fulcrum's Oral SCD Therapy Pociredir Advances in Phase 1b Trial with Key Data Expected Mid-2024
去年
ORIC Pharmaceuticals Announces Promising Early Data for ORIC-944 and Collaboration for ORIC-114
上个月
Fulcrum and Slate Medicines to Combine in Reverse Merger, Advancing Next-Generation Migraine Therapies
去年
Pipeline Analysis Reveals 85+ Drugs in Development for Metastatic Prostate Cancer Treatment
10个月前
ORIC Pharmaceuticals Publishes Breakthrough Research on Brain-Penetrant EGFR Inhibitor Enozertinib for Lung Cancer
去年
ORIC Pharmaceuticals Appoints Kevin Brodbeck as Chief Technical Officer Ahead of Phase 3 Trials
第 1 页,共 2 页
上一页
下一页